These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36538201)

  • 21. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
    Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
    Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
    Liu Y; Zhang Y; Liu D; Tan X; Tang X; Zhang F; Xia M; Chen G; He L; Zhou L; Zhu X; Liu H
    Kidney Blood Press Res; 2018; 43(6):1852-1864. PubMed ID: 30537719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of fibrinoid necrosis on the clinical features and outcomes of primary IgA nephropathy.
    Chen H; Liu Y; Wei L; Wang H; Zheng Z; Yan T; Jia J; Li D
    BMC Nephrol; 2023 Dec; 24(1):366. PubMed ID: 38082385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, pathological characteristics and outcomes of immunoglobulin A nephropathy patients with different ages.
    Wen Q; Rong R; Zhou Q; Tang X; Yang Q; Chen W; Yu X
    Nephrology (Carlton); 2020 Dec; 25(12):906-912. PubMed ID: 31576628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z; Tan J; Wang S; Dong L; Han X; Tang Y; Qin W
    Int J Med Sci; 2021; 18(13):2964-2970. PubMed ID: 34220324
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.
    Pan M; Zhou Q; Zheng S; You X; Li D; Zhang J; Chen C; Xu F; Li Z; Zhou Z; Zhang J
    Immunol Res; 2018 Jun; 66(3):381-391. PubMed ID: 29850970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyslipidemia may be a risk factor for progression in children with IgA nephropathy.
    Zhuang H; Lin Z; Zeng S; Jiang M; Chen L; Jiang X; Xu Y
    Pediatr Nephrol; 2022 Dec; 37(12):3147-3156. PubMed ID: 35347403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy.
    Wu J; Chen X; Xie Y; Yamanaka N; Shi S; Wu D; Liu S; Cai G
    Nephrol Dial Transplant; 2005 Apr; 20(4):719-27. PubMed ID: 15701667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crescentic IgA nephropathy in children.
    Shima Y; Nakanishi K; Hama T; Mukaiyama H; Sato M; Tanaka Y; Tanaka R; Kaito H; Nozu K; Sako M; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of the systemic immune inflammation index in patients with IgA nephropathy.
    Zhai Y; Sun S; Zhang W; Tian H
    Ren Fail; 2024 Dec; 46(2):2381613. PubMed ID: 39039867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN.
    Wang S; Dong L; Qin A; Tan J; Zhou X; Qin W
    Int Immunopharmacol; 2023 Jul; 120():110354. PubMed ID: 37235963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy.
    Oh HJ; Ahn SV; Yoo DE; Kim SJ; Shin DH; Lee MJ; Kim HR; Park JT; Yoo TH; Kang SW; Choi KH; Han SH
    Kidney Int; 2012 Dec; 82(12):1304-12. PubMed ID: 22895518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.
    Saleem N; Nasir H; Anwar F; Aziz M; Khurshid K; Bashir S; Khan A
    Int Urol Nephrol; 2024 Jan; 56(1):345-353. PubMed ID: 37378850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study.
    Bi TD; Zheng JN; Zhang JX; Yang LS; Liu N; Yao L; Liu LL
    BMC Nephrol; 2019 Jul; 20(1):244. PubMed ID: 31272400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cigarette smoking may accelerate the progression of IgA nephropathy.
    Wang S; Qin A; Pei G; Jiang Z; Dong L; Tan J; Tan L; Tang Y; Qin W
    BMC Nephrol; 2021 Jun; 22(1):239. PubMed ID: 34187402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in Males.
    Nagasawa Y; Yamamoto R; Shoji T; Shinzawa M; Hasuike Y; Nagatoya K; Yamauchi A; Hayashi T; Kuragano T; Moriyama T; Isaka Y; Nakanishi T
    PLoS One; 2016; 11(8):e0160828. PubMed ID: 27560997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological characteristics, risk factors and prognostic value of intrarenal vascular lesions in IgA nephropathy.
    Ruan Y; Hong F; Lin M; Wang C; Lian F; Cao F; Yang G; Huang L; Huang Q
    Eur J Intern Med; 2023 Nov; 117():91-97. PubMed ID: 37451907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R
    Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes of IgA nephropathy patients with different proportions of crescents.
    Zhang W; Zhou Q; Hong L; Chen W; Yang S; Yang Q; Chen W; Yu X
    Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.